جست‌وجوی استاد و پژوهشگر

Timothy L Sitaمشاهده پروفایل

استادیار

• Radiation Oncology
• Neuro-Oncology
• Brain Tumors
• +۳ مورد دیگر

Timothy L Sita is an Assistant Professor in the Department of Radiation Oncology at the Feinberg School of Medicine, Northwestern University. His clinical and research activities focus on advanced radiation therapy techniques and neuro-oncology. Professional Memberships: American Society for Radiation Oncology (2019 - Present) Society for Neuro-Oncology (2019 - Present) Education and Certification: MD, PhD Board Certified in Radiation Oncology, American Board of Radiology Research Interests: Dr. Sita's work centers on Radiation Oncology and Neuro-Oncology with emphasis on brain tumors (glioma and metastases), advanced radiation delivery techniques, and immune-metabolic interactions in glioma-associated epilepsy. His research integrates computational modeling with clinical radiation oncology to optimize treatment planning and outcomes. Publication Trends: Recent publications demonstrate strong interdisciplinary focus, combining deep learning (GlioPredictor for glioma risk stratification), immunotherapy mechanisms in brain tumor epilepsy, and technical innovations in hippocampus-sparing VMAT for head/neck cancer and Gamma Knife radiosurgery for multiple brain metastases. These studies reflect convergence of AI, immunology, and precision radiation delivery. Scientific Awards: No scientific awards are documented in the provided information. Advising and Grants: Student mentoring activities and grant funding details are not specified in available materials. Labs and Teams: He participates in Northwestern University Clinical and Translational Sciences Institute (NUCATS) initiatives and collaborates with multidisciplinary neuro-oncology teams at Northwestern Medicine.

• Head and Neck Cancer
• Radiation Oncology
• Cancer Immunotherapy
• +۴ مورد دیگر

Stuart J. Wong, MD, is Professor of Hematology/Oncology and Otolaryngology at the Medical College of Wisconsin (MCW). He serves in multiple leadership roles including Director of the Center for Disease Prevention Research, Program Leader of the Head and Neck Cancer Disease Oriented Team, and Chair of the MCW Cancer Center Investigator Initiated Trial Steering Committee. His hospital privileges include Froedtert Memorial Lutheran Hospital and Zablocki VA Medical Center. His research focuses on: Head and neck cancer therapeutics including chemoradiation and reirradiation strategies Immuno-oncology approaches and precision medicine targets Radiation sensitization mechanisms and fractionation optimization Novel biomarker development and translational applications Cancer prevention methodologies Publication analysis reveals concentrated work in radiation therapy optimization, immunotherapy combinations, and molecular determinants of treatment response in head and neck cancers. Recent studies emphasize precision oncology, tumor microenvironment modulation, and advanced imaging-guided radiotherapy. Honors and awards: RTOG Next Generation Investigator Award (2008) MCW Outstanding Faculty Service Award (2011) U.S. News and World Report Best Doctors (2011-2017) M Magazine Top-Rated Doctors (2013) Medical College of Wisconsin Eminent Scholar (2019) He leads multiple NCI-funded clinical trials and serves on steering committees for NRG Oncology and RTOG. Current grants focus on head and neck cancer treatment optimization, targeted therapies, and radiation-immune interactions. He coordinates multidisciplinary teams across hematology/oncology, radiation oncology, and otolaryngology departments.

Céline Engelbeenمشاهده پروفایل

مدرس

• operations research
• combinatorial optimization
• algorithms

Céline Engelbeen serves as a lecturer at ICHEC Brussels Management School, a position she has held since 2012. In her role, she teaches core subjects including mathematics, statistics, and operations research to business and management students. Additionally, she is a co-founder of the QUARESMI laboratory, an initiative dedicated to advancing research in optimization and algorithmic methods. Her academic journey began with a doctoral degree in Mathematics from the Université Libre de Bruxelles (ULB) in 2010. Her dissertation focused on the application of optimization techniques to improve radiotherapy treatments through Intensity-Modulated Radiation Therapy (IMRT). Following her PhD, she gained practical teaching experience by instructing mathematics at a secondary school in Brussels for two years before transitioning to higher education at ICHEC. Research Interests: Professor Engelbeen specializes in operations research, combinatorial optimization, and algorithm design. Her expertise bridges theoretical computer science and practical applications, particularly in healthcare optimization as demonstrated by her doctoral work. She continues to explore innovative solutions in these fields through her involvement with the QUARESMI laboratory. Laboratory Affiliation: As a co-founder of the QUARESMI laboratory, she plays a key role in shaping its research agenda. The laboratory fosters interdisciplinary collaboration and provides a platform for tackling complex optimization problems. While specific details about current projects and funding are not provided in the source text, the laboratory represents a significant contribution to the academic community at ICHEC.

• Medical Physics
• Radiation Therapy
• Brachytherapy
• +۵ مورد دیگر

Dr. Shirin Abbasi Nejad Enger is a Canada Research Chair (Tier 2) in Medical Physics at McGill University, appointed on October 1, 2019, with renewal scheduled for October 1, 2024. Her research is funded by the Canadian Institutes of Health Research. Dr. Abbasi Nejad Enger specializes in advancing precision oncology through innovative approaches to radiation therapy. Her research focuses on: Developing personalized cancer treatments using brachytherapy that preserve healthy tissue Combining artificial intelligence, medical physics, oncology, engineering, radiobiology, and detector design Using AI for personalized cancer diagnostics and treatments Applying intensity-modulated brachytherapy technology to tailor dose distribution to tumor shape Studying the effectiveness of different radiation qualities on various tumor types Her work aims to improve the precision of radiation delivery and enhance patient quality of life by reducing treatment toxicity. Awards and Recognition Canada Research Chair (Tier 2) in Medical Physics (2019-2024) Dr. Abbasi Nejad Enger's research program represents a multidisciplinary approach to advancing cancer treatment through medical physics and artificial intelligence, with a strong focus on patient-centered outcomes.

• Radiation Oncology
• Head and Neck Cancer
• Prostate Cancer
• +۷ مورد دیگر

Dr. Julie Kang is an Associate Professor of Therapeutic Radiology at Yale School of Medicine and a board-certified radiation oncologist specializing in the treatment of head and neck, prostate, bladder, and skin cancers. She is affiliated with Yale Cancer Center and practices at the Smilow Cancer Hospital Care Center at Trumbull. Dr. Kang previously worked at Memorial Sloan Kettering Cancer Center before joining Yale. Dr. Kang received her BS from Yale University (2002), followed by a PhD (2008) and MD (2010) from the University of Southern California. She completed her radiation oncology residency at UCLA (2015). Her research focuses on optimizing cancer treatment outcomes while minimizing toxicity, with particular emphasis on HPV-associated oropharyngeal cancer, laryngeal and hypopharyngeal cancers, and thyroid cancer. Dr. Kang has published over 80 papers with more than 1,030 citations, with recent work exploring radiation dose de-escalation strategies, comparative effectiveness of different radiation techniques, and applications of artificial intelligence in oncology. Dr. Kang's publication trends show a strong focus on head and neck oncology, particularly HPV-related cancers. Her research combines clinical investigation with innovative approaches like natural language processing to analyze pathology reports and AI for biomarker extraction. This multidisciplinary approach bridges traditional radiation oncology with cutting-edge computational methods. Kaiser Permanente Everyday Hero Award (2017) Kaiser Permanente Physician Merit Award (2016) Dr. Kang is actively involved in clinical trials and cooperative groups, mentoring the next generation of cancer researchers. Her work focuses on radiation therapy optimization and personalized treatment approaches. She is particularly interested in addressing cancer disparities and reducing barriers to care, ensuring equitable access to advanced cancer treatments.

• Radiation Oncology
• Thoracic Radiotherapy
• Head and Neck Cancer Treatment
• +۷ مورد دیگر

Dr. Henry S. Park is a Professor of Therapeutic Radiology at Yale School of Medicine, where he serves as Vice Chair for Clinical Research and Chief of both the Thoracic Radiotherapy Program and PET-Guided Radiotherapy Program. At the Yale Cancer Center, he is Assistant Medical Director of the Clinical Trials Office and Associate Leader of the Lung Clinical Research Team. He also serves as Head of Horstmann House in the Office of Student Affairs, overseeing one of six advisory houses for medical and physician associate students. Dr. Park received his undergraduate degree from Yale College in 2007, a Master's in Public Health from Harvard University in 2012, and his MD from Yale School of Medicine in 2012. He completed his internal medicine internship at Harvard Medical School's Beth Israel Deaconess Medical Center in 2013 before returning to Yale for his radiation oncology residency and chief residency. He joined the Yale faculty in 2017, was named associate professor and vice chair in 2022, and was promoted to Professor in 2025. His research focuses on clinical trials, real-world evidence, novel radiotherapy technology, and health services with specialization in lung and head/neck cancers. His work spans developing prognostic systems for oral cavity carcinoma, investigating optimal timing of systemic therapy in nasopharyngeal cancer, studying molecular markers in lung cancer treatment, and analyzing opioid prescribing patterns in cancer patients. Dr. Park has co-authored over 200 peer-reviewed publications and serves as an associate editor for Advances in Radiation Oncology and American Journal of Clinical Oncology. Outstanding Reviewer Award from Advances in Radiation Oncology (2023) Outstanding Reviewer Award from International Journal of Radiation Oncology (2022) Educator of the Year Award from Association of Residents in Radiation Oncology (2022) Clinician of the Year Award from Yale School of Medicine (2021) Outstanding Reviewer Award from International Journal of Radiation Oncology (2020) Dr. Park leads multiple clinical trials including the RAPTOR trial (Principal Investigator) investigating consolidation radiation + immunotherapy for extensive-stage small cell lung cancer, and the MAVERICK trial (Principal Investigator) comparing MRI brain surveillance versus prophylactic cranial irradiation in small-cell lung cancer. He also serves as Sub-Investigator on trials studying stereotactic body radiation therapy for centrally located lung cancer and oligoprogression in renal cell carcinoma. As Chief of the Thoracic Radiotherapy Program and PET-Guided Radiotherapy Program, Dr. Park oversees the application of advanced radiation techniques including stereotactic body radiation therapy, image-guided radiation therapy, and intensity-modulated radiation therapy for treating patients with lung and head/neck cancers at Smilow Cancer Hospital in New Haven.

Julie Hendryمشاهده پروفایل

دانشیار

• Radiotherapy
• Oncology
• Medical Education
• +۶ مورد دیگر

Dr Julie Hendry serves as Associate Professor in Radiotherapy and Oncology and Professional Lead/Section Head for Radiotherapy & Oncology at City St George's, University of London. She also holds the leadership position of Associate Dean for Student Outcomes across the university. With a clinical background spanning decades as a therapeutic radiographer, Dr Hendry transitioned into education in 2009 and has since established herself as an influential educator and leader in medical radiation sciences. Her educational journey includes a Doctor of Education (2022), Postgraduate Certificate in Teaching and Learning in Higher Education with Commendation (2011), and a Masters in Oncology Practice with Commendation from Kingston University (2009). She also holds a BSc in Radiotherapy Practice (1993) and the Diploma of the College of Radiographers (Therapy) (1986). Dr Hendry's research focuses on compassionate care in radiography, patient-centered approaches in radiotherapy, and educational methodologies for healthcare professionals. Her work explores how caring behaviors manifest in clinical practice and how these can be effectively taught to students. She has investigated the information needs of women receiving adjuvant radiotherapy and examined the support requirements of adolescent cancer survivors. Her research often bridges clinical practice with educational theory to improve both patient outcomes and professional development. Her publication record demonstrates a consistent focus on improving radiography education and practice. She has examined topics ranging from values-based practice in radiography to advanced radiotherapy techniques that minimize cardiac exposure in breast cancer treatment. Her recent work addresses the challenges of delivering compassionate care during the COVID-19 pandemic and developing person-centered approaches in radiotherapy. Educational Excellence Award for Programme Leadership (2020) ASRT Leadership Academy for Educators Scholarship (2011) As an educator, Dr Hendry has demonstrated strong commitment to student experience and development through her various leadership roles, including Course Director for the Therapeutic Undergraduate Programme (2014-2020). Her professional development activities reflect ongoing engagement with educational leadership, unconscious bias training, and change management strategies. She has participated in numerous conferences focused on radiography education excellence and interprofessional practice.

Betina Børresenمشاهده پروفایل

دانشیار

• Veterinary Oncology
• Comparative Oncology
• Radiation Therapy
• +۴ مورد دیگر

Betina Børresen is an Associate Professor of Veterinary and Comparative Oncology at the Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. She specializes in veterinary oncology with a focus on using canine cancer patients as models for human diseases, particularly in radiation therapy research. Education: Veterinary Medicine (DVM) from University of Copenhagen (2012) PhD in Veterinary Oncology focusing on molecular imaging and nanomedicine (2017) European Specialist in Small Animal Oncology (dipECVIM-CA onco) (2021) Betina's research primarily focuses on comparative oncology, exploring how canine cancer models can inform human cancer treatments. Her work emphasizes radiotherapy (particularly FLASH radiotherapy), immunotherapy, and molecular imaging techniques. She has established herself as a leader in veterinary radiation oncology through her innovative approaches to treating companion animals with cancer. Her research program bridges veterinary and human medicine, creating valuable translational opportunities. Her recent publications demonstrate a strong emphasis on FLASH radiotherapy applications in veterinary medicine, with multiple studies examining its efficacy and safety in canine patients. This research not only advances veterinary cancer care but also provides critical data for potential human applications of this novel radiation technique, particularly regarding dose optimization and toxicity profiles. Scientific Recognition: European Specialist in Small Animal Oncology (dipECVIM-CA onco) Diplomate of the European College of Veterinary Internal Medicine (Oncology subspecialty, 2021) Betina has secured significant research funding from major organizations including the Independent Research Fund Denmark (2022), Danish Cancer Society (2023), and several foundations supporting veterinary cancer research. She serves as the responsible person for the Danish Veterinary Cancer Registry, which provides valuable epidemiological data on cancer in companion animals. Her work with Qbiotics (Stelfonta) as a consultant demonstrates industry engagement while maintaining academic independence. Betina maintains active collaborations with medical physicists and radiation oncologists across institutions, bridging the gap between human and veterinary medicine. Her leadership of the Danish Veterinary Cancer Registry represents a significant national contribution to cancer epidemiology in companion animals, creating a valuable resource for future research and clinical decision-making.